Cotización y Noticias de Gilead Sciences, Inc.(GILD)

Mínimo/Máximo 24 Horas

Mínimo/Máximo 52 Semanas

Curing #HIV remains a formidable challenge, but our leaders believe it’s a goal worth reaching for. For Senior Research Scientist Jeff Murry, answers may lie in lessons learned from scientific fields outside of HIV.

The @US_FDA has granted accelerated approval to our antibody-drug conjugate treatment for adult patients with heavily pre-treated locally advanced or metastatic urothelial cancer (UC), the most common form of #bladdercancer: http://bit.ly/3dYUk5h

Cargar más…

CHART DE Gilead Sciences, Inc.(GILD)

Noticias de Gilead Sciences, Inc.(GILD)

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *